Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.47 |
| ▸ | FGF1 | P05230 | 1/20 | 0.45 |
| ▸ | ITPR3 | Q14573 | 5/20 | 0.44 |
| ▸ | ITPR2 | Q14571 | 2/20 | 0.44 |
| ▸ | ITPR1 | Q14643 | 2/20 | 0.44 |
| ▸ | INPP5A | Q14642 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7856353 | 0.84 | LGALS8 (0.50) | LGALS8FGF1 | |
| SCHEMBL6829446 | 0.84 | TLR4 (0.44) | LGALS8ITPR3 | |
| SCHEMBL897909 | 0.84 | TLR4 (0.44) | LGALS8ITPR3 | |
| SCHEMBL898729 | 0.84 | TLR4 (0.44) | LGALS8ITPR3 | |
| SCHEMBL4143599 | 0.83 | SMPD1 (0.47) | ITPR3ITPR2ITPR1 | |
| SCHEMBL930846 | 0.83 | IGF2R (0.51) | LGALS8ITPR3ITPR2ITPR1 | |
| SCHEMBL9236010 | 0.81 | CA2 (0.45) | ITPR3ITPR2ITPR1 | |
| SCHEMBL9234642 | 0.81 | CA2 (0.45) | ITPR3ITPR2ITPR1 | |
| SCHEMBL23705114 | 0.81 | LGALS8 (0.51) | LGALS8FGF1 | |
| SCHEMBL7147710 | 0.81 | LGALS8 (0.51) | LGALS8FGF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 322 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240084045-A1 | CROSSLINKED HYALURONIC ACID HYDROGEL CROSSLINKED USING CROSSLINKER AND POLYOL, AND FILLER COMPRISING SAME | LG CHEM, LTD. (KR) | 2024-03-14 | — | — | US | claimed |
| EP-4245328-A1 | CROSSLINKED HYALURONIC ACID HYDROGEL CROSSLINKED USING CROSSLINKER AND POLYOL, AND FILLER COMPRISING SAME | Lg Chem, Ltd. (KR) | 2023-09-20 | — | — | EP | claimed |
| CN-116615261-A | Crosslinked hyaluronic acid hydrogel crosslinked using crosslinking agent and polyol and filler comprising same | 株式会社LG化学 | 2023-08-18 | — | — | CN | claimed |
| US-20220129965-A1 | CUSTOMIZED SKIN CARE | L Ford, Inc. | 2022-04-28 | — | — | US | claimed |
| US-11257137-B2 | Customized skin care | L Ford, Inc. (US) | 2022-02-22 | — | — | US | claimed |
| CN-110960430-A | After-shave care product composition | 上海绿瑞生物科技有限公司 | 2020-04-07 | — | — | CN | claimed |
| US-20190303991-A1 | CUSTOMIZED SKIN CARE | L Ford, Inc. | 2019-10-03 | — | — | US | claimed |
| US-10124030-B2 | Skincare preparations | KARYNG, LLC (US) | 2018-11-13 | — | — | US | claimed |
| US-20170304371-A1 | SKINCARE PREPARATIONS | KARYNG, LLC | 2017-10-26 | — | — | US | claimed |
| EP-3215495-A1 | SKINCARE FORMULATIONS AND REGIMENS | Stella & Dot LLC (US) | 2017-09-13 | — | — | EP | claimed |
| WO-2016073529-A1 | SKINCARE FORMULATIONS AND REGIMENS | STELLA & DOT LLC (US) | 2016-05-12 | — | — | WO | claimed |
| US-20160120781-A1 | SKINCARE FORMULATIONS AND REGIMENS | MIDCAP FUNDING IV TRUST | 2016-05-05 | — | — | US | claimed |
| CN-117794504-A | Iris root extract, compositions and methods for dermatological use | 捷通国际有限公司 | 2024-03-29 | — | — | CN | disclosed |
| US-20240084045-A1 | CROSSLINKED HYALURONIC ACID HYDROGEL CROSSLINKED USING CROSSLINKER AND POLYOL, AND FILLER COMPRISING SAME | LG CHEM, LTD. (KR) | 2024-03-14 | — | — | US | disclosed |
| CN-117643556-A | Oral care compositions containing gel network phase | 宝洁公司 | 2024-03-05 | — | — | CN | disclosed |
| US-11896704-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2024-02-13 | — | — | US | disclosed |
| WO-2010004361-A2 | COMPOSITIONS AND METHODS FOR IMPROVING OVERALL TOOTH HEALTH AND APPEARANCE | THE PROCTER & GAMBLE COMPANY (US) | 2010-01-14 | — | — | WO | disclosed |
| WO-2009134657-A1 | ORAL CARE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2009-11-05 | — | — | WO | disclosed |
| US-20090269287-A1 | Oral Care Compositions | THE PROCTER & GAMBLE COMPANY | 2009-10-29 | — | — | US | disclosed |
| US-20080247973-A1 | Compositions and Methods for Improving Overall Tooth Health and Appearance | THE PROCTER & GAMBLE COMPANY | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11896704-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | TYR, MTX1, MTX2 | LGALS8 82/4885FGF1 1685/4885ITPR3 3327/4885 |
| US-20080247973-A1 | Compositions and Methods for Improving Overall Tooth Health and Appearance | ALPP, CHERP, CA3 | LGALS8 1196/4885FGF1 1881/4885ITPR3 87/4885 |
| US-20170304371-A1 | SKINCARE PREPARATIONS | COL14A1, COL1A1, COL2A1 | LGALS8 748/4885FGF1 6/4885ITPR3 4022/4885 |
| US-10124030-B2 | Skincare preparations | COL14A1, COL1A1, COL2A1 | LGALS8 748/4885FGF1 6/4885ITPR3 4022/4885 |
| US-20160120781-A1 | SKINCARE FORMULATIONS AND REGIMENS | XPOT, XPO7, XPA | LGALS8 1578/4885FGF1 3467/4885ITPR3 3876/4885 |
| US-20090269287-A1 | Oral Care Compositions | DSC1, GALC, TAS2R39 | LGALS8 305/4885FGF1 1644/4885ITPR3 994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.